- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Lung Cancer Liquid Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Lung Cancer Liquid Biopsy market size is estimated to be worth US$ 438 million in 2021 and is forecast to a readjusted size of USD 1056.2 million by 2028 with a CAGR of 13.4% during review period. Hospitals accounting for % of the Lung Cancer Liquid Biopsy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Exosomes and RNA segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Lung Cancer Liquid Biopsy include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, and MDxHealth, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lung Cancer Liquid Biopsy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Exosomes and RNA
CTCs and ctDNA
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Lung Cancer Liquid Biopsy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Lung Cancer Liquid Biopsy, with revenue, gross margin and global market share of Lung Cancer Liquid Biopsy from 2019 to 2022.
Chapter 3, the Lung Cancer Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Lung Cancer Liquid Biopsy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Lung Cancer Liquid Biopsy research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Lung Cancer Liquid Biopsy
1.2 Classification of Lung Cancer Liquid Biopsy by Type
1.2.1 Overview: Global Lung Cancer Liquid Biopsy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Type in 2021
1.2.3 Exosomes and RNA
1.2.4 CTCs and ctDNA
1.3 Global Lung Cancer Liquid Biopsy Market by Application
1.3.1 Overview: Global Lung Cancer Liquid Biopsy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Lung Cancer Liquid Biopsy Market Size & Forecast
1.5 Global Lung Cancer Liquid Biopsy Market Size and Forecast by Region
1.5.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Lung Cancer Liquid Biopsy Market Size by Region, (2017-2022)
1.5.3 North America Lung Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.4 Europe Lung Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Lung Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.6 South America Lung Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Lung Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Cancer Liquid Biopsy Market Drivers
1.6.2 Lung Cancer Liquid Biopsy Market Restraints
1.6.3 Lung Cancer Liquid Biopsy Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 RainDanceTechnologies
2.1.1 RainDanceTechnologies Details
2.1.2 RainDanceTechnologies Major Business
2.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Product and Solutions
2.1.4 RainDanceTechnologies Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 RainDanceTechnologies Recent Developments and Future Plans
2.2 Biocartis
2.2.1 Biocartis Details
2.2.2 Biocartis Major Business
2.2.3 Biocartis Lung Cancer Liquid Biopsy Product and Solutions
2.2.4 Biocartis Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Biocartis Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Lung Cancer Liquid Biopsy Product and Solutions
2.3.4 Qiagen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Guardant Health
2.4.1 Guardant Health Details
2.4.2 Guardant Health Major Business
2.4.3 Guardant Health Lung Cancer Liquid Biopsy Product and Solutions
2.4.4 Guardant Health Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Guardant Health Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Lung Cancer Liquid Biopsy Product and Solutions
2.5.4 MDxHealth Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Pathway Genomics
2.6.1 Pathway Genomics Details
2.6.2 Pathway Genomics Major Business
2.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Product and Solutions
2.6.4 Pathway Genomics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pathway Genomics Recent Developments and Future Plans
2.7 NeoGenomics Laboraories
2.7.1 NeoGenomics Laboraories Details
2.7.2 NeoGenomics Laboraories Major Business
2.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product and Solutions
2.7.4 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.8 Sysmex Inostics
2.8.1 Sysmex Inostics Details
2.8.2 Sysmex Inostics Major Business
2.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Product and Solutions
2.8.4 Sysmex Inostics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sysmex Inostics Recent Developments and Future Plans
2.9 Cynvenio
2.9.1 Cynvenio Details
2.9.2 Cynvenio Major Business
2.9.3 Cynvenio Lung Cancer Liquid Biopsy Product and Solutions
2.9.4 Cynvenio Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Cynvenio Recent Developments and Future Plans
2.10 Menarini Silicon Biosystems
2.10.1 Menarini Silicon Biosystems Details
2.10.2 Menarini Silicon Biosystems Major Business
2.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product and Solutions
2.10.4 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.11 Adaptive Biotechnologies
2.11.1 Adaptive Biotechnologies Details
2.11.2 Adaptive Biotechnologies Major Business
2.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product and Solutions
2.11.4 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.12 Biocept
2.12.1 Biocept Details
2.12.2 Biocept Major Business
2.12.3 Biocept Lung Cancer Liquid Biopsy Product and Solutions
2.12.4 Biocept Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Biocept Recent Developments and Future Plans
2.13 Angle plc
2.13.1 Angle plc Details
2.13.2 Angle plc Major Business
2.13.3 Angle plc Lung Cancer Liquid Biopsy Product and Solutions
2.13.4 Angle plc Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Angle plc Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Lung Cancer Liquid Biopsy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Lung Cancer Liquid Biopsy Players Market Share in 2021
3.2.2 Top 10 Lung Cancer Liquid Biopsy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Lung Cancer Liquid Biopsy Players Head Office, Products and Services Provided
3.4 Lung Cancer Liquid Biopsy Mergers & Acquisitions
3.5 Lung Cancer Liquid Biopsy New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Lung Cancer Liquid Biopsy Revenue and Market Share by Type (2017-2022)
4.2 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2017-2022)
5.2 Global Lung Cancer Liquid Biopsy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Lung Cancer Liquid Biopsy Revenue by Type (2017-2028)
6.2 North America Lung Cancer Liquid Biopsy Revenue by Application (2017-2028)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Country
6.3.1 North America Lung Cancer Liquid Biopsy Revenue by Country (2017-2028)
6.3.2 United States Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
6.3.3 Canada Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
6.3.4 Mexico Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Lung Cancer Liquid Biopsy Revenue by Type (2017-2028)
7.2 Europe Lung Cancer Liquid Biopsy Revenue by Application (2017-2028)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country
7.3.1 Europe Lung Cancer Liquid Biopsy Revenue by Country (2017-2028)
7.3.2 Germany Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.3 France Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.5 Russia Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.6 Italy Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Type (2017-2028)
8.2 Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Application (2017-2028)
8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Region (2017-2028)
8.3.2 China Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.3 Japan Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.4 South Korea Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.5 India Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.7 Australia Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Lung Cancer Liquid Biopsy Revenue by Type (2017-2028)
9.2 South America Lung Cancer Liquid Biopsy Revenue by Application (2017-2028)
9.3 South America Lung Cancer Liquid Biopsy Market Size by Country
9.3.1 South America Lung Cancer Liquid Biopsy Revenue by Country (2017-2028)
9.3.2 Brazil Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
9.3.3 Argentina Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Type (2017-2028)
10.2 Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Application (2017-2028)
10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Country (2017-2028)
10.3.2 Turkey Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
10.3.4 UAE Lung Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Lung Cancer Liquid Biopsy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Lung Cancer Liquid Biopsy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Lung Cancer Liquid Biopsy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2023-2028)
Table 6. RainDanceTechnologies Corporate Information, Head Office, and Major Competitors
Table 7. RainDanceTechnologies Major Business
Table 8. RainDanceTechnologies Lung Cancer Liquid Biopsy Product and Solutions
Table 9. RainDanceTechnologies Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Biocartis Corporate Information, Head Office, and Major Competitors
Table 11. Biocartis Major Business
Table 12. Biocartis Lung Cancer Liquid Biopsy Product and Solutions
Table 13. Biocartis Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Qiagen Corporate Information, Head Office, and Major Competitors
Table 15. Qiagen Major Business
Table 16. Qiagen Lung Cancer Liquid Biopsy Product and Solutions
Table 17. Qiagen Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Guardant Health Corporate Information, Head Office, and Major Competitors
Table 19. Guardant Health Major Business
Table 20. Guardant Health Lung Cancer Liquid Biopsy Product and Solutions
Table 21. Guardant Health Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. MDxHealth Corporate Information, Head Office, and Major Competitors
Table 23. MDxHealth Major Business
Table 24. MDxHealth Lung Cancer Liquid Biopsy Product and Solutions
Table 25. MDxHealth Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pathway Genomics Corporate Information, Head Office, and Major Competitors
Table 27. Pathway Genomics Major Business
Table 28. Pathway Genomics Lung Cancer Liquid Biopsy Product and Solutions
Table 29. Pathway Genomics Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. NeoGenomics Laboraories Corporate Information, Head Office, and Major Competitors
Table 31. NeoGenomics Laboraories Major Business
Table 32. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product and Solutions
Table 33. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sysmex Inostics Corporate Information, Head Office, and Major Competitors
Table 35. Sysmex Inostics Major Business
Table 36. Sysmex Inostics Lung Cancer Liquid Biopsy Product and Solutions
Table 37. Sysmex Inostics Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Cynvenio Corporate Information, Head Office, and Major Competitors
Table 39. Cynvenio Major Business
Table 40. Cynvenio Lung Cancer Liquid Biopsy Product and Solutions
Table 41. Cynvenio Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Menarini Silicon Biosystems Corporate Information, Head Office, and Major Competitors
Table 43. Menarini Silicon Biosystems Major Business
Table 44. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product and Solutions
Table 45. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Adaptive Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 47. Adaptive Biotechnologies Major Business
Table 48. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product and Solutions
Table 49. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Biocept Corporate Information, Head Office, and Major Competitors
Table 51. Biocept Major Business
Table 52. Biocept Lung Cancer Liquid Biopsy Product and Solutions
Table 53. Biocept Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Angle plc Corporate Information, Head Office, and Major Competitors
Table 55. Angle plc Major Business
Table 56. Angle plc Lung Cancer Liquid Biopsy Product and Solutions
Table 57. Angle plc Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Lung Cancer Liquid Biopsy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Lung Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Lung Cancer Liquid Biopsy Players Head Office, Products and Services Provided
Table 62. Lung Cancer Liquid Biopsy Mergers & Acquisitions in the Past Five Years
Table 63. Lung Cancer Liquid Biopsy New Entrants and Expansion Plans
Table 64. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Type (2017-2022)
Table 65. Global Lung Cancer Liquid Biopsy Revenue Share by Type (2017-2022)
Table 66. Global Lung Cancer Liquid Biopsy Revenue Forecast by Type (2023-2028)
Table 67. Global Lung Cancer Liquid Biopsy Revenue by Application (2017-2022)
Table 68. Global Lung Cancer Liquid Biopsy Revenue Forecast by Application (2023-2028)
Table 69. North America Lung Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Lung Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Lung Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Lung Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Lung Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Lung Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Lung Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Lung Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Lung Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Lung Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Lung Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Lung Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Lung Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Lung Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Lung Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Lung Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Lung Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Lung Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Lung Cancer Liquid Biopsy Picture
Figure 2. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type in 2021
Figure 3. Exosomes and RNA
Figure 4. CTCs and ctDNA
Figure 5. Lung Cancer Liquid Biopsy Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Others Picture
Figure 9. Global Lung Cancer Liquid Biopsy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Lung Cancer Liquid Biopsy Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2017-2028)
Figure 12. Global Lung Cancer Liquid Biopsy Revenue Market Share by Region in 2021
Figure 13. North America Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Lung Cancer Liquid Biopsy Market Drivers
Figure 19. Lung Cancer Liquid Biopsy Market Restraints
Figure 20. Lung Cancer Liquid Biopsy Market Trends
Figure 21. RainDanceTechnologies Recent Developments and Future Plans
Figure 22. Biocartis Recent Developments and Future Plans
Figure 23. Qiagen Recent Developments and Future Plans
Figure 24. Guardant Health Recent Developments and Future Plans
Figure 25. MDxHealth Recent Developments and Future Plans
Figure 26. Pathway Genomics Recent Developments and Future Plans
Figure 27. NeoGenomics Laboraories Recent Developments and Future Plans
Figure 28. Sysmex Inostics Recent Developments and Future Plans
Figure 29. Cynvenio Recent Developments and Future Plans
Figure 30. Menarini Silicon Biosystems Recent Developments and Future Plans
Figure 31. Adaptive Biotechnologies Recent Developments and Future Plans
Figure 32. Biocept Recent Developments and Future Plans
Figure 33. Angle plc Recent Developments and Future Plans
Figure 34. Global Lung Cancer Liquid Biopsy Revenue Share by Players in 2021
Figure 35. Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Lung Cancer Liquid Biopsy Revenue Market Share in 2021
Figure 37. Global Top 10 Players Lung Cancer Liquid Biopsy Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Lung Cancer Liquid Biopsy Revenue Share by Type in 2021
Figure 40. Global Lung Cancer Liquid Biopsy Market Share Forecast by Type (2023-2028)
Figure 41. Global Lung Cancer Liquid Biopsy Revenue Share by Application in 2021
Figure 42. Global Lung Cancer Liquid Biopsy Market Share Forecast by Application (2023-2028)
Figure 43. North America Lung Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 44. North America Lung Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 45. North America Lung Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 46. United States Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Lung Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 50. Europe Lung Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 51. Europe Lung Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 52. Germany Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Lung Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Lung Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Lung Cancer Liquid Biopsy Revenue Market Share by Region (2017-2028)
Figure 60. China Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Lung Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 67. South America Lung Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 68. South America Lung Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Lung Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Lung Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Lung Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Lung Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
